Announcements Trials
Browse Landscape

Phase

Phase 2 9Phase 3 3Phase 1 3Phase 1/2 2

Status

Unknown 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 2FED 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Stomach Neoplasms 1Neoplasm Metastasis 1Fibrosis 1Colorectal Neoplasms 1Carcinoma, Hepatocellular 1

Interventions

Fluorouracil 309Oxaliplatin 260Leucovorin 234Capecitabine 198Irinotecan 147Gemcitabine 128Cisplatin 126Bevacizumab 119Radiotherapy 72Paclitaxel 64Folfox protocol 56Cetuximab 56Drug Therapy 46Sorafenib 45Docetaxel 42S 1 (combination) 40Chemotherapy, Adjuvant 38Neoadjuvant Therapy 37pembrolizumab 36130-nm albumin-bound paclitaxel 29Surgical Procedures, Operative 27regorafenib 25lenvatinib 24XELOX 24Radiation 24Panitumumab 24Nivolumab 23atezolizumab 22Carboplatin 22trifluridine tipiracil drug combination 21

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Simvastatin × Gastrointestinal × Clear all
NCT03654053 2026-01-07

SACRED

VA Office of Research and Development

Phase 3 Active not recruiting
142 enrolled
Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular

NCT01099085 2017-02-17

Trial of XP (Capecitabine/CDDP) Simvastatin in Advanced Gastric Cancer Patients

Samsung Medical Center

Phase 3 Completed
207 enrolled
Gastrointestinal

Neoplasm Metastasis, Stomach Neoplasms

NCT01238094 2013-06-14

Trial of XELIRI/FOLFIRI + Simvastatin Followed by Simvastatin Maintenance in Metastatic Colorectal Cancer

Samsung Medical Center

Phase 3 Unknown
258 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡